OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Integrated microbiome and metabolome analysis reveals the interaction between intestinal flora and serum metabolites as potential biomarkers in hepatocellular carcinoma patients
Xiaoyue Li, Yongxiang Yi, Tongxin Wu, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 12
Xiaoyue Li, Yongxiang Yi, Tongxin Wu, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 12
Showing 12 citing articles:
Metabolomic biomarkers in liquid biopsy: accurate cancer diagnosis and prognosis monitoring
Wenqian Wang, Shan-Shan Zhen, Ping Yu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 7
Wenqian Wang, Shan-Shan Zhen, Ping Yu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 7
Gut Microbiome Modulation in Hepatocellular Carcinoma: Preventive Role in NAFLD/NASH Progression and Potential Applications in Immunotherapy-Based Strategies
Elisa Monti, Clara Vianello, Ilaria Leoni, et al.
Cells (2025) Vol. 14, Iss. 2, pp. 84-84
Open Access
Elisa Monti, Clara Vianello, Ilaria Leoni, et al.
Cells (2025) Vol. 14, Iss. 2, pp. 84-84
Open Access
Correlation of non-alcoholic fatty liver disease and gut microflora: clinical reports and treatment options
Pranali Jadhav, Asha Thomas, Rabindra K. Nanda, et al.
Egyptian Liver Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Pranali Jadhav, Asha Thomas, Rabindra K. Nanda, et al.
Egyptian Liver Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Gut microbial metabolites: Shaping future diagnosis and treatment against gastrointestinal cancer
Hongyan Gou, Ruijie Zeng, Harry Cheuk-Hay Lau, et al.
Pharmacological Research (2024) Vol. 208, pp. 107373-107373
Open Access | Times Cited: 3
Hongyan Gou, Ruijie Zeng, Harry Cheuk-Hay Lau, et al.
Pharmacological Research (2024) Vol. 208, pp. 107373-107373
Open Access | Times Cited: 3
Analysis of Metabolic Changes in Endogenous Metabolites and Diagnostic Biomarkers for Various Diseases Using Liquid Chromatography and Mass Spectrometry
Masamitsu Maekawa
Biological and Pharmaceutical Bulletin (2024) Vol. 47, Iss. 6, pp. 1087-1105
Open Access | Times Cited: 2
Masamitsu Maekawa
Biological and Pharmaceutical Bulletin (2024) Vol. 47, Iss. 6, pp. 1087-1105
Open Access | Times Cited: 2
The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma
Betül Gök Yavuz, Saumil Datar, Shadi Chamseddine, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4875-4875
Open Access | Times Cited: 6
Betül Gök Yavuz, Saumil Datar, Shadi Chamseddine, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4875-4875
Open Access | Times Cited: 6
The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma
Betül Gök Yavuz, Saumil Datar, Shadi Chamseddine, et al.
(2023)
Open Access | Times Cited: 4
Betül Gök Yavuz, Saumil Datar, Shadi Chamseddine, et al.
(2023)
Open Access | Times Cited: 4
The Role of Mass Spectrometry in Hepatocellular Carcinoma Biomarker Discovery
Eric Yi-Liang Shen, Mei Ran Abellona U, I. Jane Cox, et al.
Metabolites (2023) Vol. 13, Iss. 10, pp. 1059-1059
Open Access | Times Cited: 3
Eric Yi-Liang Shen, Mei Ran Abellona U, I. Jane Cox, et al.
Metabolites (2023) Vol. 13, Iss. 10, pp. 1059-1059
Open Access | Times Cited: 3
Decoding the microbiota metabolome in hepatobiliary and pancreatic cancers: Pathways to precision diagnostics and targeted therapeutics
Yuemiao Xu, Jiahan Le, Jiang‐Jiang Qin, et al.
Pharmacological Research (2024) Vol. 208, pp. 107364-107364
Open Access
Yuemiao Xu, Jiahan Le, Jiang‐Jiang Qin, et al.
Pharmacological Research (2024) Vol. 208, pp. 107364-107364
Open Access
Gut Microbiome and Hepatic Transcriptomic Determinants of HCC Development in Mice with Metabolic Dysfunction-Associated Steatohepatitis
Lillian I Dolapchiev, Kristyn Gonzales, Lorenzo R. Cruz, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 1891-1905
Open Access
Lillian I Dolapchiev, Kristyn Gonzales, Lorenzo R. Cruz, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 1891-1905
Open Access
Novel Biomarkers for Early Detection of Hepatocellular Carcinoma
Abdelrahman M. Attia, Mohammad Saeid Rezaee‐Zavareh, Soo Young Hwang, et al.
Diagnostics (2024) Vol. 14, Iss. 20, pp. 2278-2278
Open Access
Abdelrahman M. Attia, Mohammad Saeid Rezaee‐Zavareh, Soo Young Hwang, et al.
Diagnostics (2024) Vol. 14, Iss. 20, pp. 2278-2278
Open Access
Analysis of the Circulating Metabolome of Patients with Cutaneous, Mucosal and Uveal Melanoma Reveals Distinct Metabolic Profiles with Implications for Response to Immunotherapy
Maysa Vilbert, Érica Koch, April A. N. Rose, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3708-3708
Open Access | Times Cited: 1
Maysa Vilbert, Érica Koch, April A. N. Rose, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3708-3708
Open Access | Times Cited: 1
